MedTrace Logo

Evaluation of Valvular Heart Disease Using Cardiac CT

NCT06937125 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2025-05-14

No results posted yet for this study

Summary

The EVIDENTIA Registry is a multicenter study designed to evaluate valvular heart disease (VHD) using cardiac CT. It aims to assess cardiac valve anatomy, function, and myocardial characteristics through detailed CT analysis.

1. Assessing the accuracy of cardiac CT in evaluating cardiac structure, volume, function, and myocardium in VHD patients.
2. Comparing the severity, classification, and etiology (primary vs. functional) of VHD.
3. Monitoring serial changes in VHD severity via echocardiography.
4. Investigating the relationship between echocardiographic and CT-derived parameters.
5. Examining the correlation between imaging findings, VHD interventions, and patient prognosis.

Conditions

  • Valvular Heart Disease

Sponsors & Collaborators

  • Toho University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-12
Primary Completion
2027-03-31
Completion
2028-03-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06937125 on ClinicalTrials.gov